ReposiTrak (TRAK) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
17 Nov, 2025Executive summary
Revenue grew 10% year-over-year to $6 million for the quarter ended September 30, 2025, driven by recurring subscription revenue in compliance, supply chain, and traceability services.
Operating income rose 28% to $1.9 million, and net income increased to $1.8 million, with EPS up 13% to $0.10 basic and $0.09 diluted.
The company maintains a focus on automation, AI, and customer care, driving efficiency and profitability.
Strong cash position with $28.8 million and no bank debt at quarter end.
Recurring revenue comprises 99% of total revenue.
Financial highlights
Revenue increased from $5.4 million to $6 million, a 10% year-over-year rise.
Operating expenses rose 3%, mainly due to investments in RTN, cybersecurity, and higher SG&A costs.
Gross margin remained above 80%, with cost of services and product support decreasing 1% year-over-year.
Cash from operations was $1.5 million, down from $1.9 million due to deferred revenue conversion and increased receivables.
Net other income increased due to higher interest income.
Outlook and guidance
Management aims to double company size over several years, focusing on recurring revenue, profitability, and returning half of free cash to shareholders.
Tax rate expected to rise above 6% as NOLs are exhausted; exploring credits to mitigate impact.
Multi-year software modernization and automation initiatives underway to drive future efficiencies and growth.
Sufficient liquidity and cash flow expected to fund operations and investments for at least the next twelve months.
Marketing spend expected to flatten as traceability awareness increases.
Latest events from ReposiTrak
- Q2 revenue up 7%, EPS up 13%, strong cash, no debt, and leadership in traceability.TRAK
Q2 202617 Feb 2026 - Record revenue, net income, and cash with accelerating traceability and higher dividends.TRAK
Q4 202420 Jan 2026 - Traceability and retailer mandates drove 8% revenue growth and a 10% dividend increase.TRAK
Q1 202513 Jan 2026 - Deferred revenue up 70% and double-digit growth expected, fueled by traceability demand.TRAK
Q2 202523 Dec 2025 - Director elections, auditor ratification, and executive pay aligned with performance highlight the meeting.TRAK
Proxy Filing1 Dec 2025 - Preliminary proxy statement filed, detailing voting matters and shareholder procedures.TRAK
Proxy Filing1 Dec 2025 - Annual meeting covers director elections, executive pay, auditor ratification, and governance.TRAK
Proxy Filing1 Dec 2025 - Preliminary proxy outlines voting items and governance for the upcoming shareholder meeting.TRAK
Proxy Filing1 Dec 2025 - Q3 revenue up 16% and net income up 27%, with strong recurring revenue and cash flow.TRAK
Q3 202526 Nov 2025